THE EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I), IGF-II AND DES(1-3)IGF-I, A POTENT IGF ANALOG, ON GROWTH-HORMONE AND IGF-BINDING PROTEIN SECRETION FROM CULTURED RAT ANTERIOR-PITUITARY-CELLS

被引:26
作者
SIMES, JM
WALLACE, JC
WALTON, PE
机构
[1] CSIRO, DIV HUMAN NUTR, POB 10041, GOUGER ST, ADELAIDE, SA 5000, AUSTRALIA
[2] UNIV ADELAIDE, DEPT BIOCHEM, ADELAIDE, SA 5000, AUSTRALIA
关键词
D O I
10.1677/joe.0.1300093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I, a potent IGF-I analogue, on the secretion of GH and IGF-binding protein (IGFBP) from cultured rat anterior pituitary cells were measured. IGF-I and des(1-3)IGF-I stimulated GH secretion at low concentrations (maximally effective at 1 and 0.1-mu-g/l respectively) and inhibited GH secretion at higher concentrations. The half-maximal inhibitory concentrations (IC50) were approximately 20-mu-g/l and 1-mu-g/l for IGF-I and des(1-3)IGF-I respectively. Thus des(1-3)IGF-I was more potent than IGF-I in these effects on GH secretion. We postulate that the increased potency of des(1-3)IGF-I in affecting GH secretion is due to decreased binding of this peptide by pituitary IGFBP compared with IGF-I. In contrast with IGF-I and des(1-3)IGF-I, IGF-II did not stimulate GH secretion at low concentrations, but did inhibit GH secretion from pituitary cells with an IC50 of approximately 20-mu-g/l. Several IGFBPs ranging in molecular mass from 22 000 to 52 000 were detected in medium conditioned by cultured anterior pituitary cells. When measured by Western-ligand blotting and competitive ligand-binding techniques, these IGFBPs exhibited decreased binding of des(1-3)IGF-I compared with IGF-I and IGF-II. The production of IGFBP by anterior pituitary cells was stimulated by the addition of IGFs to the culture medium.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 36 条
  • [1] HUMAN GROWTH-HORMONE AND SOMATOMEDIN-C SUPPRESS THE SPONTANEOUS RELEASE OF GROWTH-HORMONE IN UNANESTHETIZED RATS
    ABE, H
    MOLITCH, ME
    VANWYK, JJ
    UNDERWOOD, LE
    [J]. ENDOCRINOLOGY, 1983, 113 (04) : 1319 - 1324
  • [2] A KEY FUNCTIONAL-ROLE FOR THE INSULIN-LIKE GROWTH FACTOR-I N-TERMINAL PENTAPEPTIDE
    BAGLEY, CJ
    MAY, BL
    SZABO, L
    MCNAMARA, PJ
    ROSS, M
    FRANCIS, GL
    BALLARD, FJ
    WALLACE, JC
    [J]. BIOCHEMICAL JOURNAL, 1989, 259 (03) : 665 - 671
  • [3] BALLARD FJ, 1989, BIOCHEM SOC SYMP, V55, P91
  • [4] BALLARD FJ, 1990, 72ND ANN M END SOC A
  • [5] ON THE NOMENCLATURE OF THE IGF BINDING-PROTEINS
    BALLARD, J
    BAXTER, R
    BINOUX, M
    CLEMMONS, D
    DROP, S
    HALL, K
    HINTZ, R
    RECHLER, M
    RUTANEN, E
    SCHWANDER, J
    [J]. ACTA ENDOCRINOLOGICA, 1989, 121 (05): : 751 - 752
  • [6] Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0
  • [7] SOMATOMEDIN-C MEDIATES GROWTH-HORMONE NEGATIVE FEEDBACK BY EFFECTS ON BOTH THE HYPOTHALAMUS AND THE PITUITARY
    BERELOWITZ, M
    SZABO, M
    FROHMAN, LA
    FIRESTONE, S
    CHU, L
    HINTZ, RL
    [J]. SCIENCE, 1981, 212 (4500) : 1279 - 1281
  • [8] BINOUX M, 1983, INSULIN LIKE GROWTH, P571
  • [9] ISOLATION AND CHARACTERIZATION OF VARIANT IGF-1 AS WELL AS IGF-2 FROM ADULT HUMAN-BRAIN
    CARLSSONSKWIRUT, C
    JORNVALL, H
    HOLMGREN, A
    ANDERSSON, C
    BERGMAN, T
    LUNDQUIST, G
    SJOGREN, B
    SARA, VR
    [J]. FEBS LETTERS, 1986, 201 (01) : 46 - 50
  • [10] FACTORS CONTROLLING BLOOD-CONCENTRATION OF SOMATOMEDIN-C
    CLEMMONS, DR
    VANWYK, JJ
    [J]. CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1984, 13 (01): : 113 - 143